
FDA Clears C2N Diagnostics’ PrecivityAD2® — First Alzheimer’s Blood Test for Adults with Cognitive Symptoms as Young as 40
<a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxOSU42MGw0ZlprWC16RWxQSHVZOXZOYmtfQ2FpZ0F3aG1hSG9mMUFSYlZEa01ldU5Ec09Dc2lMWXVpRWF3X2JPdmRBZHNoY3JzYVIwZkg2b2RJamlkdXJweFZtQUIxZmFVSlliem1Tb0paajJlVVdrWnpfMVFsV05rTEIteEdkTHlHU0Q5VUNicFBGSDdnNTVKSUd0ZVNzQTk4dDJFU3pic3FLNjhtZFRtMFBYNE1JRHhyRzVfVVo4UWNCV3VoVW1ROFhubHVTWGJxbmJwcFJHaXY5czg4SndIRnR4UFhvQXRFWl80eW1B?oc=5" target="_blank">FDA Clears C2N Diagnostics’ PrecivityAD2® — First Alzheimer’s Blood Test for Adults with Cognitive Symptoms as Young as 40</a>&nbsp;&nbsp;<font color="#6f6f6f">BioSpace</font>
